Ralaniten triacetate

• Description:

  Ralaniten triacetate (EPI-506), a precursor of Ralaniten, is a first-of-its-kind, orally active androgen receptor N-terminal structural domain (AR-NTD) inhibitor with anticancer activity and can be used to study prostate and breast cancer.

• Stability:

  ≥ 2 years

• Purity:

  >98% (HPLC)

• Weight:

  521

• Molecular Formula:

  C27H33ClO8

• Notes:

  Research use only, not for human use.

• Receptor:

  Androgen Receptor

• CAS Number:

  1637573-04-6